BM
LXRX icon

Bridger Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bridger Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-336,966
Closed -$6.09M – 43
2016
Q3 		$6.09M Sell
336,966
-692,960
-67% -$11.2M 0.41% 37
2016
Q2 		$14.8M Hold
1,029,926
– – 0.95% 33
2016
Q1 		$12.3M Sell
1,029,926
-413,941
-29% -$4.34M 0.85% 33
2015
Q4 		$19.2M Buy
1,443,867
+151,499
+12% +$1.86M 0.64% 27
2015
Q3 		$13.9M Buy
1,292,368
+1,032,910
+398% +$11.3M 0.95% 30
2015
Q2 		$2.09M Buy
+259,458
New +$1.91M 0.07% 42

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bridger Management's LXRX Position: Q4 2016 in Review

Bridger Management sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2016, closing a stake of 336,966 shares — an estimated $6.09M sold.

Bridger Management first reported a position in LXRX in Q2 2015 and held it in 6 quarters. The position peaked at $19.2M in Q4 2015. 145 funds tracked by Wall St. Rank hold LXRX as of Q4 2016.

  • Bridger Management reported no remaining Lexicon Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Bridger Management sold 336,966 Lexicon Pharmaceuticals shares in Q4 2016, an estimated $6.09M.
  • Bridger Management first reported a position in Lexicon Pharmaceuticals in Q2 2015 and held it in 6 quarters.
  • Bridger Management's Lexicon Pharmaceuticals position peaked at $19.2M in Q4 2015.
  • 145 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2016.

Based on Bridger Management's 13F filing for Q4 2016, filed 14 Feb 2017.